Artificial intelligence-based multi-omics analysis fuels cancer precision medicine

X He, X Liu, F Zuo, H Shi, J Jing - Seminars in Cancer Biology, 2023 - Elsevier
With biotechnological advancements, innovative omics technologies are constantly
emerging that have enabled researchers to access multi-layer information from the genome …

Machine learning for multi-omics data integration in cancer

Z Cai, RC Poulos, J Liu, Q Zhong - Iscience, 2022 - cell.com
Multi-omics data analysis is an important aspect of cancer molecular biology studies and
has led to ground-breaking discoveries. Many efforts have been made to develop machine …

Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American …

K Manickam, MR McClain, LA Demmer, S Biswas… - Genetics in …, 2021 - nature.com
Purpose To develop an evidence-based clinical practice guideline for the use of exome and
genome sequencing (ES/GS) in the care of pediatric patients with one or more congenital …

TMB or not TMB as a biomarker: That is the question

A Addeo, A Friedlaender, GL Banna… - Critical reviews in oncology …, 2021 - Elsevier
Immune checkpoint inhibitors (ICIs) have revolutionized the landscape of therapeutic
options for many cancers. These treatments have demonstrated improved efficacy and often …

Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders

B Sadikovic, MA Levy, J Kerkhof, E Aref-Eshghi… - Genetics in …, 2021 - nature.com
Purpose We describe the clinical implementation of genome-wide DNA methylation analysis
in rare disorders across the EpiSign diagnostic laboratory network and the assessment of …

[HTML][HTML] Application of next generation sequencing in laboratory medicine

Y Zhong, F Xu, J Wu, J Schubert… - Annals of laboratory …, 2021 - synapse.koreamed.org
The rapid development of next-generation sequencing (NGS) technology, including
advances in sequencing chemistry, sequencing technologies, bioinformatics, and data …

Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis

B Acharya, A Acharya, S Gautam, SP Ghimire… - Molecular biology …, 2020 - Springer
Tuberculosis (TB) is a major cause of deaths by a single infectious agent and has now been
a global public health problem due to increasing numbers of drug-resistant cases. Early and …

[HTML][HTML] The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom

K Schwarze, J Buchanan, JM Fermont, H Dreau… - Genetics in …, 2020 - Elsevier
Purpose The translation of genome sequencing into routine health care has been slow,
partly because of concerns about affordability. The aspirational cost of sequencing a …

Advancing personalized medicine through the application of whole exome sequencing and big data analytics

P Suwinski, CK Ong, MHT Ling, YM Poh… - Frontiers in …, 2019 - frontiersin.org
There is a growing attention toward personalized medicine. This is led by a fundamental
shift from the 'one size fits all'paradigm for treatment of patients with conditions or …

Complexities in understanding antimicrobial resistance across domesticated animal, human, and environmental systems

DW Graham, G Bergeron, MW Bourassa… - Annals of the New …, 2019 - Wiley Online Library
Antimicrobial resistance (AMR) is a significant threat to both human and animal health. The
spread of AMR bacteria and genes across systems can occur through a myriad of pathways …